Davies Lab

Publications

Davies, SM; Ross, JA. Childhood cancer etiology: recent reports. Pediatric Blood and Cancer. 2003; 40:35-38.

ROSS, JA; DAVIES, SM; ROBISON, LL. Is it possible to catch leukaemia from a cat?. The Lancet. 1994; 344:1580.

ROSS, JA; DAVIES, SM; POTTER, JD; ROBISON, LL. Epidemiology of childhood leukemia, with a focus on infants. Epidemiologic Reviews. 1994; 16:243-272.

DAVIES, SM. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma. Cancer Research. 1993; 53:4781-4783.

Ramsay, NK; Davies, S. Bone marrow transplant for acute leukaemia. Best Practice & Research: Clinical Haematology. 1991; 4:483-510.

Ibrahimova, A; Luebbering, N; Langenberg, L; Abdullah, S; Strecker, L; Lake, KE; Lane, A; Webster, A; Myers, KC; Jodele, S; Davies, SM. Kinetics of DNases after hematopoietic stem cell transplant. 2025; 2:100055.

Marsh, R; Khoury, R; Mizuno, K; Hosawi, A; Cottrell, C; Nguyen, E; Landon, B; Chandra, S; Jordan, M; Kumar, A; Bleesing, J; Davies, S; Moore, C; Mehta, P. Precision Alemtuzumab Dosing Results in Day 0 Target Range Achievement in 80% of IEI Patients and Minimizes Risks of GVHD, Clinically Significant Mixed Chimerism, and Secondary Graft Failure. 2025; 1.

Khoury, R; Jordan, M; Bleesing, J; Kumar, A; Saldana, BD; Verkamp, B; Davies, S; Marsh, R; Chandra, S. Addition of Thiotepa to Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Reduces Secondary Graft Failure in Allogeneic HSCT for Inborn Errors of Immunity. 2025; 1.

Mehta, PA; Nelson, A; Loveless, S; Lane, A; Fukuda, T; Teusink-Cross, A; Elder, D; Lagory, D; Miller, E; Cancelas, JA; Edwards, S; Chihanga, T; Wells, SI; Davies, SM. Phase 1 study of quercetin, a natural antioxidant for children and young adults with Fanconi anemia. Blood Advances. 2025; 9:1927-1939.

Dandoy, CE; Auletta, JJ; Badia, P; Bidgoli, A; Daraiseh, NM; DeSalvo, AM; Diaz, J; Davies, SM; Demmel, K; Cook, E; Salem, BM; Snyder, A; Juckett, M; Hartley, D. Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes. Transplantation and Cellular Therapy. 2025; 31:123-134.

Merli, P; Jodele, S; Cook, E; Myers, KC; Lane, A; Ryhänen, S; Cefalo, MP; Quagliarella, F; Davies, SM; Teusink-Cross, A; Kohorst, M; Corsetti, T; Locatelli, F; Sabulski, A. Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT. Bone Marrow Transplantation. 2025; 60:406-411.

Myers, KC; Davies, SM; Lutzko, C; Wahle, R; Grier, DD; Aubert, G; Norris, K; Baird, DM; Koga, M; Ko, AC; Amano, T; Amano, M; Yu, H; Ko, MS H. Clinical Use of ZSCAN4 for Telomere Elongation in Hematopoietic Stem Cells. 2025; 4:EVIDoa2400252.

Cook, E; Langenberg, L; Luebbering, N; Ibrahimova, A; Myers, KC; Sabulski, A; Dandoy, C; Lake, K; Ziady, A; Lane, A; Webster, A; Abdullah, S; Jodele, S; Davies, SM. Oxidative Stress Early After Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2025; 31:135.e1-135.e10.

Abdullah, S; Sabulski, DA; Hudda, DZ; Ziady, AG; Luebbering, N; Langenberg, L; Odegard, E; Blackard, JT; Kleiboeker, S; Jodele, S; Seif, AE; Davies, SM; Laskin, B. Bkpyv Replication Kinetics and Association with Hemorrhagic Cystitis in Pediatric HSCT Recipients. Transplantation and Cellular Therapy. 2025; 31:s515-s516.

Ramos, KN; Ginocchio, MP; Gutarra, ME; Ghalehsari, N; Pandey, M; Shah, R; Davies, SM; Auletta, DJ J; Arteaga, AG; Hall, AG. Perception and Reality of Racial and Ethnic Workforce Diversity in the U.S HCT/CT Workforce: Results from the ASTCT-NMDP Access Initiative Survey. Transplantation and Cellular Therapy. 2025; 31:s342.

Verkamp, B; Dandoy, DC E; Badia, P; Haslam, D; Davies, SM; Khandelwal, P. Characterizing the Gut Microbiome in Pediatric Patients Undergoing Hematopoietic Cell Transplant for a Non-Malignant Diagnosis. Transplantation and Cellular Therapy. 2025; 31:s316-s317.

Ashraf, A; Lake, KE; Myers, KC; Towe, C; Cooper, R; Edwards, MS L; Hils, B; Davies, SM; Koo, DJ. Frequent Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Brief Transpire Report. Transplantation and Cellular Therapy. 2025; 31:s149-s150.

Koo, DJ; Miller, E; O'Conner, A; Campbell, KM; Grompe, M; Myers, KC; Mehta, PA; Davies, SM. Beyond Graft-Vs-Host Disease: The Role of Cellular Senescence in Persistent Liver Injury in Fanconi Anemia after HSCT. Transplantation and Cellular Therapy. 2025; 31:s311-s312.

Bender, J; Davies, SM; Myers, KC; Benoit, SW. Beyond Survival: Assessing Renal and Cardiovascular Health in Fanconi Anemia Adolescents and Young Adults Post-Stem Cell Transplant. Transplantation and Cellular Therapy. 2025; 31:s375-s376.

McCormack-Spivey, S; Strecker, L; Webster, A; Davies, SM; Sabulski, DA. Plasma LILRA6 Levels Influence BK Polyomavirus Cystitis after HSCT. Transplantation and Cellular Therapy. 2025; 31:s514-s515.

Ibrahimova, A; Ashraf, A; Klink, G; Teusink-Cross, A; Davies, SM; Khandelwal, P. Single Center Experience of Belumosudil in Children < 12 Years, Adolescents and Young Adults. Transplantation and Cellular Therapy. 2025; 31:s305-s306.

McCormack-Spivey, S; Sabulski, DA; Davies, SM; Chandra, S. Defining and Assessing Poor Graft Function after Allogeneic HSCT in Children and Young Adults. Transplantation and Cellular Therapy. 2025; 31:s317-s318.

Ginocchio, MP; Ramos, KN; Gutarra, ME; Ghalehsari, N; Pandey, M; Shah, R; Davies, SM; Auletta, DJ J; Arteaga, AG; Hall, AG. Physician Workforce Diversity in the Hematopoietic Cell Transplant and Cellular Therapy Ecosystem: An ASTCT-NMDP Access Initiative Survey. Transplantation and Cellular Therapy. 2025; 31:s361.

Ashraf, A; Murphey, C; Sper, C; Webster, A; Lane, A; Mesa, S; Garcia, F; Perez, MR; Chamblin, C; Davies, SM; Khandelwal, P. Male Gender and Underlying Diagnosis Predisposes to Increased HLA Antibody Burden in Children before Allogeneic Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2025; 31:s147.

Neidemire-Colley, L; Zhao, Q; Miller, EG; Langenberg, L; Elder, P; Hahn, TE; Bejanyan, N; Davies, SM; Ranganathan, P; Vasu, S. Soluble Fms-like Tyrosine Kinase-1 (sFlt-1) As a Clinical Biomarker for Individual Susceptibility to Post-Transplant Complications: A Report from the MIDAS Consortium. Transplantation and Cellular Therapy. 2025; 31:s26-s27.

Ginocchio, MP; Gutarra, ME; Ramos, KN; Shah, R; Pandey, M; Ghalehsari, N; Davies, SM; Auletta, DJ J; Hall, AG; Arteaga, AG. Understanding Diversity: An ASTCT-NMDP Access Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Nonphysician Workforce. Transplantation and Cellular Therapy. 2025; 31:s343-s344.

Vasu, S; Zhao, Q; Miller, EG; Habib, A; Elder, P; Davies, SM; Bejanyan, N; Hahn, TE. Pre-HCT Creatinine and Early Post-HCT Changes in Creatinine and Blood Pressure Associate with Severe Transplant Associated Thrombotic Microangiopathy (TA-TMA): A Report from the MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium. Transplantation and Cellular Therapy. 2025; 31:s149.

Taggart, CB; Bota, KE; Young, K; Wall, J; Davies, SM; Dandoy, DC E; Ramos, KN. Inbody Assessments Reveal Important Changes in Body Mass Composition during HCT. Transplantation and Cellular Therapy. 2025; 31:s146.

Davies, SM; Grimley, MS; Shrestha, A; Shova, A; Asnani, M; Kent, M; Sayani, F; Quinn, CT; Niss, O; Lutzko, CM; Witting, S; Latham, T; Bushman, FD; Malik, P. Gene Therapy with Reduced-Intensity Conditioning for Sickle Cell Disease. Transplantation and Cellular Therapy. 2025; 31:s2-s3.

Webster, A; Jodele, S; Luebbering, N; Davies, SM; Sabulski, DA. Single Cell Rnaseq Identifies Novel Graft Rejection Mechanisms and Resurgence of Recipient NK and T-Cells. Transplantation and Cellular Therapy. 2025; 31:s307-s308.

Verkamp, B; Soliman, A; Davies, SM; Krupski, C. Influence of the Incorporation of a Muslim Chaplain on Medical Decision-Making in a Pediatric Hematopoietic Cell Transplant Program. Transplantation and Cellular Therapy. 2025; 31:s355.

Koo, DJ; Lake, KE; Langenberg, L; Anderson, J; Edwards, MS L; Teusink-Cross, A; Romick-Rosendale, L; Sabulski, DA; Jodele, S; Davies, SM. Pravastatin Prophylaxis Is Safe and Feasible in Children and Young Adults Undergoing Allogeneic HSCT: A Prospective, Single Arm Cohort Study. Transplantation and Cellular Therapy. 2025; 31:s153-s154.

Hudda, DZ; Schoettler, ML; Rotz, SJ; Kapadia, M; Lehmann, LE; Freedman, JL; Pater, L; Weiss, B; Badia, P; Davies, SM; Mormann, M; Desai, A; Webster, A; Dandoy, DC E. Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study. Transplantation and Cellular Therapy. 2025; 31:s93-s94.

Koo, DJ; Webster, A; Dandoy, DC E; Jodele, S; Davies, SM; Sabulski, DA. The Tell-Tale Heart: A Cytokine Storm Story of Pericardial Effusions after HSCT. Transplantation and Cellular Therapy. 2025; 31:s137.

Manjrekar, P; Sabulski, DA; Lies, E; Dandoy, DC E; Davies, SM; Laskin, B; Jodele, S. The HCT Protein Shake: Moderate and Severe Proteinuria Are Specific to TA-TMA. Transplantation and Cellular Therapy. 2025; 31:s145.

Strecker, L; Webster, A; Luebbering, N; Laskin, B; Seif, AE; Blackard, JT; Jodele, S; Odegard, E; Davies, SM; Sabulski, DA. The Novel Role of Pilra in BK Polyomavirus Cystitis after HSCT. Transplantation and Cellular Therapy. 2025; 31:s167.

Ramos, KN; Zee, J; Sabulski, DA; Laskin, B; Blackard, JT; Langenberg, L; Dandoy, DC E; Davies, SM; Jodele, S. Pre-Transplant Complement Activation and Transplant-Associated Thrombotic Microangiopathy (TA-TMA) across Diagnostic Groups. Transplantation and Cellular Therapy. 2025; 31:s25-s26.

Maier, S; Auletta, DJ J; Badia, P; Cook, E; Craddock, JA; Culbertson, C; Daraiseh, N; Davies, SM; DeSalvo, AM; Diaz, J; Nishitani, M; Snyder, AJ; Dandoy, DC E; Parker, L. Establishing a Quality Improvement Education Platform in the Engraft Learning Network. Transplantation and Cellular Therapy. 2025; 31:s501.

Grassia, KL; Diseroad, E; Jodele, S; Dandoy, DC E; Towe, C; Davies, SM; Sabulski, DA. Managing Diffuse Alveolar Hemorrhage in Pediatric HSCT with Inhaled and Intrabronchial Therapy: A Case Series of Targeted Hemostatic Intervention. Transplantation and Cellular Therapy. 2025; 31:s153.

Boldt, A; Bender, J; Jodele, S; Davies, SM; Benoit, SW. Differential Filtration of Macromolecules: A Novel Indicator of Mortality Risk in Pediatric HSCT Patients. Transplantation and Cellular Therapy. 2025; 31:s145-s146.

Snyder, AJ; Strecker, L; Langenberg, L; Davies, SM; Koo, DJ; Elder, P; Zhao, Q; Bejanyan, N; Hahn, TE; Vasu, S. Pre-Transplant Endothelial Activation May Increase Individual Susceptibility Transplant-Associated Thrombotic Microangiopathy in Adults: A Report from the MIDAS Consortium. Transplantation and Cellular Therapy. 2025; 31:s133-s134.

Abdullah, S; Sabulski, A; Hudda, Z; Ziady, A; Luebbering, N; Giordullo, L; Odegard, E; Blackard, JT; Kleiboeker, S; Altrich, M; Jodele, S; Seif, AE; Davies, SM; Laskin, BL. Susceptibility to BK polyomavirus-associated hemorrhagic cystitis in children undergoing allogeneic transplant. Haematologica: the hematology journal. 2025; 110:527-531.

McCormack-Spivey, S; Laskin, B; Seif, AE; Blackard, JT; Odegard, E; Kleiboeker, S; Jodele, S; Bourgeois, T; Zee, J; Davies, SM; Sabulski, DA. The First Prospective Screening Study of BK Polyomavirus (BKPyV) Hemorrhagic Cystitis after HSCT. Transplantation and Cellular Therapy. 2025; 31:s513-s514.

Koo, DJ; Webster, A; Myers, KC; Davies, SM; Davies, SM; Sabulski, DA. Transcriptomic Alterations and Clonal Evolution Identifies a Pre-Emptive Indication for Hematopoietic Stem Cell Transplant in Fanconi Anemia. Transplantation and Cellular Therapy. 2025; 31:s308-s309.

Mizuno, K; Teusink-Cross, A; Sabulski, DA; Davies, SM; Jodele, S. Unraveling the Challenges of Non-Responders to the Eculizumab Treatment with High-Risk Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA). Transplantation and Cellular Therapy. 2025; 31:s542-s543.

Hudda, Z; Flannery, A; Dillhoff, P; Webster, K; Jacobs, J; Strong, S; Detzel, J; Davies, SM; Khandelwal, P. Chronic Graft-Versus-Host Disease Adversely Impacts School Performance in Children and Young Adults. Transplantation and Cellular Therapy. 2025; 31:99.e1-99.e11.

Spears, K; Meyer, R; Goodin, CS; Kusnier, K; Nell, O; Pearson, P; Sanchez, M; Sarver, S; Haslam, D; Dandoy, DC E; Davies, SM; Badia, P. Scrubbing Olympics: Next Steps. Transplantation and Cellular Therapy. 2025; 31:s489.

Sabulski, DA; Webster, A; Langenberg, L; Luebbering, N; Dandoy, DC E; Koo, DJ; Jodele, S; Davies, SM. TA-TMA Evolution and Individual Susceptibility at the Proteome Level. Transplantation and Cellular Therapy. 2025; 31:s133.

Langenberg, L; Abdullah, S; Lies, E; Benoit, SW; Ramos, KN; Jodele, S; Davies, SM; Sabulski, DA. Urine Kidney Injury Biomarkers Predict TMA Risk in Pediatric HSCT Recipients. Transplantation and Cellular Therapy. 2025; 31:s314.

Ashraf, A; Davies, SM; Jodele, S; Sabulski, DA. A 10-Year History of Graft Failure in Pediatric Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2025; 31:s148-s149.

Hahn, TE; Zhao, Q; Miller, EG; Elder, P; Langenberg, L; Davies, SM; Bejanyan, N; Vasu, S. Incidence of Transplant-Associated Thrombotic Microangiopathy (TA-TMA) Is Not Lowered By Reduction of Acute GvHD (aGvHD) in Patients Receiving Post-Transplant Cyclophosphamide (PTCy) GvHD Prophylaxis: A Report from the MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium. Transplantation and Cellular Therapy. 2025; 31:s282.

Langenberg, L; Jodele, S; Davies, SM; Sabulski, DA. Supar Is a Novel and Powerful Biomarker of TMA and Kidney Injury after HSCT. Transplantation and Cellular Therapy. 2025; 31:s313-s314.

Koo, J; Huber, J; Badia, P; Dunseath, C; O'Connor, G; Davies, SM; Dandoy, CE. Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients. Pediatric Blood and Cancer. 2024; 71:e31336.

Auletta, JJ; Holter-Chakrabarty, J; Munshi, P; Wall, S; Khera, N; Knutson, J; Gomez-Arteaga, A; Hall, AG; Foster, J; Ruffin, A; Robb, D; Nemecek, E; Rouce, R; Davies, SM. Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and Cellular Therapy. 2024; 30:1124-1138.

Walder, TA; Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. Rare BK polyomavirus subtype III detected in hematopoietic cell transplant recipient. Editor, Matthijnssens J. Microbiology Resource Announcements. 2024; 13:e0067624.

Koo, J; Howell, JC; Hornung, L; Sabulski, A; Mehta, PA; Davies, SM; Myers, KC. Infrequent fractures and resilient bone mineral density: bone health in patients with Fanconi anemia. Haematologica: the hematology journal. 2024; 109:3435-3438.

Khoury, R; Grimley, MS; Nelson, AS; Leemhuis, T; Cancelas, JA; Cook, E; Wang, YZ; Heyenbruch, D; Bollard, CM; Keller, MD; Hanley, PJ; Lutzko, C; Pham, G; Davies, SM; Rubinstein, JD. Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant. American Journal of Transplantation. 2024; 24:1634-1643.

Shanthikumar, S; Goldfarb, S; Abts, M; Barochia, A; Bergeron, A; Blinman, T; Bracken, J; Calvo, C; Casey, A; Charbek, E; Teusink-Cross, A; Towe, CT; Walkup, LL; Yanik, GA. Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplantation: An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 2024; 210:262-280.

Shanthikumar, S; Gower, WA; Cooke, KR; Bergeron, A; Schultz, KR; Barochia, A; Tamae-Kakazu, M; Charbek, E; Reardon, EE; Calvo, C; Towe, CT; Yanik, GA; Iyer, NP; Goldfarb, SB. Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children: Time for a Rethink?. Transplantation and Cellular Therapy. 2024; 30:760-769.

Bartlett, AL; Wagner, JE; Jones, B; Wells, S; Sabulski, A; Fuller, C; Davies, SM. Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia. Blood Advances. 2024; 8:3027-3037.

Chokshi, SM; Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. Uncommon BK polyomaviruses detected in allogeneic hematopoietic cell transplant recipients. Editor, Matthijnssens J. Microbiology Resource Announcements. 2024; 13:e0000524.

Wang, YZ M; Huber, JF; Flesch, L; Demmel, K; Lane, A; Beebe, DW; Crosby, LE; Hogenesch, JB; Smith, DF; Davies, SM; Dandoy, CE. Trajectory of Sleep, Depression, and Quality of Life in Pediatric HSCT Recipients. Transplantation and Cellular Therapy. 2024; 30:632.e1-632.e5.

Chokshi, SM; Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. Uncommon BK polyomaviruses detected in allogeneic hematopoietic cell transplant recipients. Microbiology Resource Announcements. 2024; 13.

Cook, E; Dong, M; Chiang, SC C; Luedeke, D; Lake, KE; Hoerth, C; Deavy, M; Setchell, KD R; Zhao, J; Punt, N; Davies, SM; Marsh, RA; Mehta, P; Khandelwal, P. Ruxolitinib Pharmacokinetics and Pharmacodynamics in Children with Acute and Chronic Graft-versus-Host Disease. Transplantation and Cellular Therapy. 2024; 30:528.e1-528.e12.

Klages, KL; Schwartz, LE; Crabtree, EJ S; Brokamp, C; Rasnick, E; Dandoy, CE; Davies, SM; Pai, AL H. Social determinants of health predict health outcomes following pediatric allogeneic hematopoietic stem cell transplant. Pediatric Blood and Cancer. 2024; 71:e30892.

Ramos, KN; Leino, D; Luebbering, N; Grimley, MS; Badia, P; Davies, SM; Khandelwal, P. Use of Teduglutide in the Management of Gastrointestinal Graft-versus-Host Disease in Children and Young Adults. Transplantation and Cellular Therapy. 2024; 30:454.e1-454.e6.

Sarkar, N; Myers, KC; Lane, A; Davies, SM; Benoit, SW. Pre-transplant glomerular hyperfiltration is not a risk factor for increased renal morbidity and mortality in pediatric stem cell transplant patients. Pediatric Blood and Cancer. 2024; 71:e30853.

Snyder, AJ; Campbell, KM; Lane, A; Mehta, PA; Myers, K; Davies, SM; Koo, J. Liver abnormalities are frequent and persistent in patients with Fanconi anemia. Blood Advances. 2024; 8:1427-1438.

Khandelwal, P; Langenberg, L; Luebbering, N; Lake, KE; Butcher, A; Bota, K; Ramos, KN; Taggart, C; Choe, H; Vasu, S; Watanabe-Chailland, M; Haslam, DB; Lane, A; Davies, SM. A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults. Blood. 2024; 143:1181-1192.

Jodele, S; Dandoy, CE; Aguayo-Hiraldo, P; Lane, A; Teusink-Cross, A; Sabulski, A; Mizuno, K; Laskin, BL; Freedman, J; Davies, SM. A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation-associated TMA. Blood. 2024; 143:1112-1123.

Hudda, Z; Flannery, A; Teusink-Cross, A; Davies, SM; Khandelwal, P. Topical ruxolitinib is promising as sole or adjunctive therapy in treating maculopapular rash of acute and chronic skin GVHD. Bone Marrow Transplantation. 2024; 59:425-427.

Ramos, KN; Langenberg, L; Strecker, L; Luebbering, N; Davies, SM; Khandelwal, P. Lower Levels of the Vitamin A Transporter Serum Amyloid A1 (SAA1) Are Associated with Improved HSCT Outcomes in Children and Young Adults. Transplantation and Cellular Therapy. 2024; 30:s134-s135.

Verkamp, B; Jodele, S; Marsh, RA; Sabulski, DA; Davies, SM; Jordan, MB. Emapalumab Therapy Prior to Hematopoietic Stem Cell Transplant Is Associated with Improved Long-Term Chimerism and Event-Free Survival in Pediatric Patients with Hemophagocytic Lymphohistiocytosis. Transplantation and Cellular Therapy. 2024; 30:s93.

Strecker, L; Towe, C; Sabulski, DA; Langenberg, L; Libermann, TA; Dillon, ST; Gu, X; Davies, SM; Koo, DJ; Myers, KC. Proteomic Analysis of Bronchoalveolar Lavage Fluid from Children with Bronchiolitis Obliterans Syndrome Identifies Potential Treatment Strategies. Transplantation and Cellular Therapy. 2024; 30:s252-s253.

Leever, G; Segev, N; Hornung, L; Myers, KC; Davies, SM; Howell, JC; Langenberg, L; Luebbering, N; Sabulski, DA. A Standardized Approach to Bone Health Screening in Pediatric HSCT and the Study of Bone Health Biomarkers. Transplantation and Cellular Therapy. 2024; 30:s348-s349.

Langenberg, L; Davies, SM; Koo, DJ. Hypusine Modulation in Hematopoietic Stem Cell Transplant Recipients: A Novel Insight into GI Gvhd Mechanisms. Transplantation and Cellular Therapy. 2024; 30:s250.

Luebbering, N; Abdullah, S; Roskin, K; Webster, A; Blackard, JT; Odegard, E; Laskin, B; Seif, AE; Jodele, S; Davies, SM; Sabulski, DA. Single Cell Rnaseq Identifies Chemokine Responses to BK Polyomavirus Infection and Novel Contribution of MAIT Cells. Transplantation and Cellular Therapy. 2024; 30:s84.

Towe, C; Patti, J; Stevens, CA; Myers, KC; Cook, E; Cooper, R; Abts, MF; Baker, KS; Ballard, S; Urrego, FA; Melton, A; Noori, S; Woods, JC; Davies, SM; Goldfarb, SB. Feasibility of Home Spirometry for Early Identification of Pulmonary Dysfunction after HSCT in the Transpire Research Study. Transplantation and Cellular Therapy. 2024; 30:s138-s139.

Vasu, S; Bejanyan, N; Miller, EG; Elder, P; Zhao, Q; Davies, SM; Hahn, TE. TA-TMA Is Frequent, but Not All TA-TMA Is Actionable in Adult Allogeneic HCT Patients: A Report from the MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium. Transplantation and Cellular Therapy. 2024; 30:s19.

Spears, K; Goodin, CS; Meyer, R; Kusnier, K; Haslam, D; Dandoy, DC E; Davies, SM; Badia, P. The Scrubbing Olympics. Transplantation and Cellular Therapy. 2024; 30:s69-s70.

Hudda, Z; Flannery, A; Dilhoff, P; Webster, K; Jacobs, J; Strong, S; Detzel, J; Davies, SM; Khandelwal, P. Chronic Graft Versus Host Disease Adversely Affects School Performance and Quality of Life in Children and Young Adults. Transplantation and Cellular Therapy. 2024; 30:s43-s44.

Abdullah, S; Leever, G; Langenberg, L; Luebbering, N; Roskin, K; Webster, A; Jodele, S; Davies, SM; Sabulski, DA. Intra- and Inter-Organ Endothelial Cell Differences Contribute to TA-TMA through HMOX1, Hypoxia and Reactive Oxygen Species Signaling. Transplantation and Cellular Therapy. 2024; 30:s142.

Ramos, KN; Lake, KE; Hoerth, C; Langenberg, L; Luebbering, N; Haslam, D; Newburg, D; Morrow, AL; Ollberding, NJ; Denson, LA; Watanabe-Chailland, M; Romick-Rosendale, L; Davies, SM; Khandelwal, P. Administration of Human Milk Oligosaccharide (2′-fucosyllactose) Reduces Dysbiosis and Increases Short Chain Fatty Acids in Children and Young Adults Following HSCT: A Prospective, Single-Center Study. Transplantation and Cellular Therapy. 2024; 30:s16.

Snyder, AJ; Miller, E; O'Conner, A; Campbell, KM; Mehta, PA; Myers, KC; Davies, SM; Koo, DJ. Frequent Fanconi Anemia-Associated Liver Abnormalities before and after HSCT. Transplantation and Cellular Therapy. 2024; 30:s291-s292.

Sabulski, DA; Langenberg, L; Luebbering, N; Libermann, TA; Dillon, ST; Koo, J; Myers, KC; Jodele, S; Davies, SM. Plasma Proteome Analyses Identify Predictors of Graft Rejection Prior to Stem Cell Infusion and Support Interferon-Mediated Ferroptosis As a Novel Mechanism of Graft Rejection. Transplantation and Cellular Therapy. 2024; 30:s4-s5.

Koo, DJ; Hornung, L; Sabulski, DA; Mehta, PA; Howell, JC; Davies, SM; Myers, KC. Longitudinal Bone Health in Patients with Fanconi Anemia and Other Major Inherited Bone Marrow Failure Syndromes. Transplantation and Cellular Therapy. 2024; 30:s291.

Koo, J; Langenberg, L; Luebbering, N; Strecker, L; Abdullah, S; Carusone, E; Deavy, M; Hoerth, C; Miller, G; Turner, D; Ziady, AG; Myers, KC; Jodele, S; Davies, SM. Ceramides Are Elevated in Transplant-Associated Thrombotic Microangiopathy in Hematopoietic Stem Cell Transplant Recipients and Are a Druggable Target for Prophylaxis. Transplantation and Cellular Therapy. 2024; 30:s17-s18.

Ramos, KN; Leino, D; Luebbering, N; Grimley, M; Badia, P; Davies, SM; Khandelwal, P. Successful Use of Teduglutide As Adjunctive Therapy in the Management of GI GvHD in Children and Young Adults: A Single Center Case Series. Transplantation and Cellular Therapy. 2024; 30:s136.

Abts, MF; Silva-Carmona, M; Allen, JL; Doherty, EE; Baker, S; MacMillan, ML; Genatassio, A; Lacher, P; Griffin, T; Tekman, M; Edwards, SL; Woods, JC; Davies, SM; Goldfarb, SB. Success and Feasibility of Multiple Breath Washout: Prospective, Multi-Center Results from the Transpire Study. Transplantation and Cellular Therapy. 2024; 30:s142-s143.

Clark, D; Abdullah, S; Sabulski, DA; Towe, C; Langenberg, L; Davies, SM; Koo, DJ; Myers, KC. An in Vitro Patient-Derived Model of Bronchiolitis Obliterans Syndrome Yields New Insight into Steroid Sensitivity and Resistance. Transplantation and Cellular Therapy. 2024; 30:s252.

Huber, J; Dexheimer, J; Vaughn, L; Wall, J; O'Connor, G; Badia, P; Davies, SM; Dandoy, DC E. HSCT Patient and Family Education Concept Identification. Transplantation and Cellular Therapy. 2024; 30:s344-s345.

Koo, DJ; Huber, J; Badia, P; Dunseath, C; O'Connor, G; Davies, SM; Dandoy, DC E. Invasive Fungal Infections Are Rare in Pediatric and Young Adult Autologous Hematopoietic Stem Cell Transplant Patients. Transplantation and Cellular Therapy. 2024; 30:s122.

Sabulski, A; Abdullah, S; Luebbering, N; Aunins, B; Castillo, C; Lake, K; Duell, A; Strecker, L; Langenberg, L; Broomhead, W; Dandoy, CE; Laskin, BL; Jodele, S; Davies, SM. Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma. Haematologica: the hematology journal. 2023; 108:3449-3453.

Auletta, JJ; Holter-Chakrabarty, J; Jain, T; Miller, B; Ward, E; Khera, N; Gomez-Arteaga, A; Hall, A; Nemecek, E; Robb, D; Yusuf, RA; Davies, SM. Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and Cellular Therapy. 2023; 29:739-746.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. BK Polyomavirus Diversity After Hematopoietic Stem Cell Transplantation. The Journal of Infectious Diseases. 2023; 228:1208-1218.

Auletta, JJ; Khera, N; DeMartino, P; Kelkar, AH; Yusuf, RA; Davies, SM; Knutson, J; Beaver, E; Maloney, A; Majhail, NS. Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS Initiative. Transplantation and Cellular Therapy. 2023; 29:713-720.

Koo, J; Ziady, AG; Reynaud, D; Abdullah, S; Luebbering, N; Kahn, S; Langenberg, L; Strecker, L; Lake, K; Dandoy, CE; Siefert, ME; Skala, E; Jodele, S; Davies, SM. Increased Body Mass Index Augments Endothelial Injury and Clinical Outcomes after Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2023; 29:704.e1-704.e8.

Wang, YM; Abdullah, S; Luebbering, N; Langenberg, L; Duell, A; Lake, K; Lane, A; Hils, B; Silva, OV; Trapp, M; Haslam, DB; Faubion, WA; Davies, SM; Khandelwal, P. Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis. Blood Advances. 2023; 7:5137-5151.

Koo, J; Grom-Mansencal, I; Howell, JC; Rios, JM; Mehta, PA; Davies, SM; Myers, KC. Gonadal function in pediatric Fanconi anemia patients treated with hematopoietic stem cell transplant. Haematologica: the hematology journal. 2023; 108:2358-2368.

Bartlett, AL; Zhang, G; Wallace, G; McLean, S; Myers, KC; Teusink-Cross, A; Taggart, C; Patel, B; Davidson, R; Davies, SM; Jodele, S. Optimized vitamin D repletion with oral thin film cholecalciferol in patients undergoing stem cell transplant. Blood Advances. 2023; 7:4555-4562.

Khandelwal, P; Lounder, DT; Bartlett, A; Haberman, Y; Jegga, AG; Ghandikota, S; Koo, J; Luebbering, N; Leino, D; Abdullah, S; Karns, R; Nelson, AS; Denson, LA; Davies, SM. Transcriptome analysis in acute gastrointestinal graft-versus host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease. Haematologica: the hematology journal. 2023; 108:1803-1816.

Phillips, CL; Krupski, C; Khoury, R; Dandoy, CE; Nelson, AS; Galletta, TJ; Faulhaber, A; Davies, SM; Rubinstein, JD. Post CAR T-cell therapy outcomes and management in HSCT-naive patients: a single-center experience. Frontiers in Hematology. 2023; 2:1151744.

Galletta, TJ; Rubinstein, JD; Krupski, C; Nelson, AS; Khoury, R; Dandoy, CE; Davies, SM; Phillips, CL. Durable remissions achieved with reinfusion of CD19-directed CAR-T despite failure to induce or maintain B-cell aplasia and single-center experience with reinfusion of tisagenlecleucel. Pediatric Blood and Cancer. 2023; 70:e30271.

Galletta, TJ; Lane, A; Lutzko, C; Leemhuis, T; Cancelas, JA; Khoury, R; Wang, YZ M; Hanley, PJ; Keller, MD; Bollard, CM; Davies, SM; Grimley, MS; Rubinstein, JD. Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults. Transplantation and Cellular Therapy. 2023; 29:305-310.

Rubinstein, JD; Breese, EH; Krupski, MC; O'Brien, MM; Dandoy, CE; Mizukawa, B; Khoury, R; Norris, RE; Davies, SM; Phillips, CL. The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL. Transplantation and Cellular Therapy. 2023; 29:311.e1-311.e7.

Wang, YZ M; Loveless, M; Miller, E; Nelson, AS; Mehta, PA; Davies, SM; Myers, KC. Phenotypes of adults with Fanconi anaemia. British Journal of Haematology. 2023; 201:133-139.

Wang, YZ M; Taggart, CB; Huber, JF; Davies, SM; Smith, DF; Hogenesch, JB; Dandoy, CE. Daytime-restricted parenteral feeding is associated with earlier oral intake in children following stem cell transplant. The Journal of Clinical Investigation. 2023; 133:e167275.

Wang, YM; Taggart, CB; Huber, J; Davies, SM; Smith, DF; Hogenesch, JB; Dandoy, DC E. 167 Earlier Oral Intake in Pediatric Stem Cell Transplant Patients Receiving Time-Restricted Feeding: A Prospective, Randomized Trial. Transplantation and Cellular Therapy. 2023; 29:s135.

Zhang, G; Odegard, E; Sabulski, DA; Jodele, S; Ziady, A; Seif, AE; Davies, SM; Laskin, B; Blackard, JT. 441 Evolution of BK Polyomavirus in Immunocompromised Pediatric Patients. Transplantation and Cellular Therapy. 2023; 29:s333-s334.

Sabulski, DA; Myers, K; Davies, SM; Jodele, S. 406 All Eyes on Interferon in Graft Failure after Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2023; 29:s306-s307.

Galletta, TJ; Dong, M; Vinks, AA; Chiang, SC C; Teusink-Cross, A; Marsh, RA; Davies, SM; Mehta, PA; Khandelwal, P. 356 Children Under 2 Years Old Treated with Ruxolitinib for Acute and Chronic Graft-Versus-Host-Disease Demonstrate Variable Pharmacokinetics. Transplantation and Cellular Therapy. 2023; 29:s271-s272.

Bender, JD; Oquendo-del Toro, H; Benoit, J; Howell, JC; Badia, P; Davies, SM; Grimley, MS; Jodele, S; Phillips, C; Burns, K; Rose, SR; Hoefgen, H; Khandelwal, P; Myers, KC. Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2023; 29:130.e1-130.e8.

Sabulski, DA; Siefert, ME; Skala, E; Abdullah, S; Luebbering, N; Myers, K; Odegard, E; Blackard, JT; Seif, AE; Jodele, S; Davies, SM; Laskin, B; Ziady, A. 77 Proteomic Analyses Reveal Molecular Connections That Support the Clinical Association of Cystitis with Thrombotic Microangiopathy in Pediatric Transplant Recipients. Transplantation and Cellular Therapy. 2023; 29:s64-s65.

Odegard, E; Meeds, H; Kleiboeker, S; Ziady, A; Sabulski, DA; Jodele, S; Seif, AE; Davies, SM; Laskin, B; Blackard, JT. 429 BK Polyomavirus after Pediatric Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2023; 29:s324-s325.

Koo, DJ; Reynaud, D; Ziady, A; Kahn, S; Abdullah, S; Luebbering, N; Strecker, L; Lake, KE; Giordullo, L; Ibrahimova, A; Good, S; Dandoy, DC E; Myers, K; Jodele, S; Davies, SM. 166 Reduced Sphingosine-1-Phosphate Leads to Hypoxemia and Lung Injury after Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2023; 29:s134.

Auletta, JJ; Sandmaier, BM; Jensen, E; Majhail, NS; Knutson, J; Nemecek, E; Ajayi-Hackworth, F; Davies, SM. The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem. Transplantation and Cellular Therapy. 2022; 28:802-809.

Sabulski, A; Abdullah, S; Luebbering, N; Aunins, B; Castillo, C; Lake, K; Duell, A; Strecker, L; Giordullo, L; Broomhead, W; Dandoy, CE; Laskin, BL; Jodele, S; Davies, SM. Circulating endothelial cells and the study of vascular injury in children undergoing hematopoietic stem cell transplant. Haematologica: the hematology journal. 2022; 107:2950-2954.

Myers, KC; Davies, SM; Lutzko, C; Wahle, R; Aubert, G; Amano, T; Amano, M; Yu, H; Ko, MS H. Successful Ex Vivo Telomere Elongation with Exg-001 in a Patient with a Dyskeratosis Congenita. Blood. 2022; 140:1895-1896.

Sabulski, A; Wallace, G; Lane, A; Davies, SM; Myers, KC. Azithromycin does not increase hematologic relapse in pediatric hematopoietic cell transplant recipients. Bone Marrow Transplantation. 2022; 57:1589-1591.

Addison, J; Razzaghi, H; Bailey, C; Dickinson, K; Corathers, SD; Hartley, DM; Utidjian, L; Carle, AC; Rhodes, ET; Alonso, GT; Eckrich, D; Magnusen, B; Davies, SD; Walsh, KE. Testing an Automated Approach to Identify Variation in Outcomes among Children with Type 1 Diabetes across Multiple Sites. Pediatric Quality and Safety. 2022; 7:e602.

Khandelwal, P; Chaturvedi, V; Owsley, E; Efebera, YA; Choe, H; Bostic, M; Kumchala, P; Rajgolikar, G; Ranganathan, P; Garzon, R; Jordan, MB; Vasu, S; Devine, S; Marsh, RA. Prospective two center study of CD38 bright CD8+ effector memory T-cells as a predictor of acute GVHD. Transplantation Reports. 2022; 7:100100.

Chiang, SC C; Owsley, E; Panchal, N; Chaturvedi, V; Terrell, CE; Jordan, MB; Mehta, PA; Davies, SM; Akeno, N; Booth, C; Marsh, RA. Quercetin ameliorates XIAP deficiency-associated hyperinflammation. Blood. 2022; 140:706-715.

Sabulski, A; Arcuri, G; Szabo, S; Care, MM; Dandoy, CE; Davies, SM; Jodele, S. Cerebral vascular injury in transplant-associated thrombotic microangiopathy. Blood Advances. 2022; 6:4310-4319.

Rubinstein, JD; Lutzko, C; Leemhuis, T; Zhu, X; Pham, G; Ray, L; Thomas, S; Dourson, C; Wilhelm, J; Lane, A; Wang, YZ M; Davies, SM; Nelson, AS; Grimley, MS. Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant. Blood Advances. 2022; 6:2897-2907.

Sabulski, A; Grier, DD; Myers, KC; Davies, SM; Rubinstein, JD. Acute myeloid leukemia in SRP54-mutated congenital neutropenia. eJHaem. 2022; 3:521-525.

Chihanga, T; Vicente-Muñoz, S; Ruiz-Torres, S; Pal, B; Sertorio, M; Andreassen, PR; Khoury, R; Mehta, P; Davies, SM; Lane, AN; Romick-Rosendale, LE; Wells, SI. Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia. Cancers. 2022; 14:2040.

Mizuno, K; Dandoy, CE; Teusink-Cross, A; Davies, SM; Vinks, AA; Jodele, S. Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT. Blood Advances. 2022; 6:1454-1463.

Galletta, TJ; Lane, A; Lutzko, CM; Leemhuis, T; Cancelas, JA; Khoury, R; Wang, YM; Hanley, PJ; Keller, MD; Bollard, CM; Davies, SM; Grimley, MS; Rubinstein, JD. 477 Availability of Donor Derived Patient Specific Virus-Specific T-Cells (VSTs) Is Not Associated with Differences in Outcomes As Compared to Frontline Administration of Third Party Vsts for the Management of Viral Infections after Pediatric Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2022; 28:s374-s375.

Gardner, JC; Courter, JD; Dandoy, CE; Davies, SM; Teusink-Cross, A. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients. Transplantation and Cellular Therapy. 2022; 28:167.e1-167.e5.

Mizuno, K; Dandoy, CE; Teusink-Cross, A; Davies, SM; Vinks, A; Jodele, S. 187 Eculizumab Precision Dosing Algorithm for TA-TMA in Children and Young Adults Undergoing Stem Cell Transplant. Transplantation and Cellular Therapy. 2022; 28:s154-s155.

Vasu, S; Bostic, M; Zhao, Q; Sharma, N; Puto, M; Knight, S; Scott, D; Guzman, R; Kromer, M; Tackett, K; Jaglowski, S; Penza, S; Davies, SM; Cataland, S. Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults. Blood Advances. 2022; 6:1342-1349.

Rubinstein, JD; Jodele, S; Heyenbruch, D; Wilhelm, J; Thomas, S; Lutzko, C; Zhu, X; Leemhuis, T; Cancelas, JA; Keller, M; Mims, A; Davies, SM; Grimley, MS; Nelson, AS. Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients. Transplantation and Cellular Therapy. 2022; 28:116.e1-116.e7.

Wang, YZ M; Teusink-Cross, A; Elborai, Y; Krupski, MC; Nelson, AS; Grimley, MS; Flannery, A; Mehta, PA; Bleesing, JJ; Chandra, S; Kumar, AR; Myers, KC; Davies, SM; Khandelwal, P. Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults. Transplantation. 2022; 106:412-419.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. BK Polyomavirus Subtypes II and IV in Hematopoietic Cell Transplant Recipients. Editor, Roux S. Microbiology Resource Announcements. 2022; 11:e0105321.

Furutani, E; Liu, S; Galvin, A; Steltz, S; Malsch, MM; Loveless, SK; Mount, L; Larson, JH; Queenan, K; Bertuch, AA; Davies, SM; Weller, E; Myers, KC; Shimamura, A. Hematologic complications with age in Shwachman-Diamond syndrome. Blood Advances. 2022; 6:297-306.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. Optimized amplification of BK polyomavirus in urine. Journal of Virological Methods. 2022; 299:114319.

Chandra, S; Mizuno, K; Zhao, J; Davies, SM; Marsh, RA; Fukuda, T; Setchell, KD R; Vinks, AA; Mehta, PA. Test-dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non-malignant disorders. British Journal of Clinical Pharmacology. 2022; 88:115-127.

Wang, YZ M; Gloude, NJ; Davies, SM; Lucky, AW; Nelson, AS. Reply to: Comment on: Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients. Pediatric Blood and Cancer. 2022; 69:e29432.

Arnold, DE; Emoto, C; Fukuda, T; Dong, M; Vinks, AA; Lane, A; McIntosh, K; Neumeier, L; Lankester, AC; Achini, F; Myers, KC; Davies, SM; Mehta, PA; Marsh, RA. A prospective pilot study of a novel alemtuzumab target concentration intervention strategy. Bone Marrow Transplantation. 2021; 56:3029-3031.

Kennedy, AL; Myers, KC; Bowman, J; Gibson, CJ; Camarda, ND; Furutani, E; Muscato, GM; Klein, RH; Ballotti, K; Liu, S; Bahl, C; Carter, SL; Shimamura, A; Lindsley, RC. Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome. Nature Communications. 2021; 12:1334.

Walkup, LL; Myers, KC; Willmering, MM; Mehta, PA; Nelson, AS; Fleck, RJ; Woods, JC; Davies, SM; Towe, CT. Modern Lung Magnetic Resonance Imaging to Screen for Pulmonary Complications in Patients with Dyskeratosis Congenita. American Journal of Respiratory and Critical Care Medicine. 2021; 204:1340-1343.

Sabulski, A; Myers, KC; Bleesing, JJ; Duell, A; Lane, A; Teusink-Cross, A; Davies, SM; Jodele, S. Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure. Blood Advances. 2021; 5:4594-4604.

Davies, SM. Grasping the sword of Damocles. Blood. 2021; 138:1792-1793.

Wallace, G; Rosen, N; Towbin, AJ; Jodele, S; Myers, KC; Davies, SM; Flannery, A; Gurria, JP. Pneumatosis intestinalis after hematopoietic stem cell transplantation: When not doing anything is good enough. Journal of Pediatric Surgery. 2021; 56:2073-2077.

Koo, J; Teusink-Cross, A; Davies, SM; Jodele, S; Dandoy, CE. Single-center results reporting improved hematopoietic stem cell mobilization success in pediatric and young adult patients with solid tumors and lymphoma. Pediatric Blood and Cancer. 2021; 68:e29319.

Rubinstein, JD; Zhu, X; Leemhuis, T; Pham, G; Ray, L; Emberesh, S; Jodele, S; Thomas, S; Cancelas, JA; Bollard, CM; Davies, SM; Nelson, AS; Grimley, MS; Lutzko, C. Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted. Blood Advances. 2021; 5:3309-3321.

Khandelwal, P; Teusink-Cross, A; Kumar, AR; Bleesing, JJ; Mehta, PA; Jordan, MB; Chandra, S; Davies, SM; Marsh, RA. Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series. British Journal of Haematology. 2021; 194:e84-e89.

Wang, YZ M; Gloude, NJ; Davies, SM; Lucky, AW; Nelson, AS. Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients. Pediatric Blood and Cancer. 2021; 68:e29231.

McGrady, ME; Mara, CA; Geiger-Behm, K; Ragsdale, J; Davies, SM; Schwartz, LA; Phipps, S; Pai, AL H. Psychometric evaluation of the brief RCOPE and relationships with psychological functioning among caregivers of children undergoing hematopoietic stem cell transplant. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer. 2021; 30:1457-1465.

Levine, JE; Grupp, SA; Pulsipher, MA; DIetz, AC; Rives, S; Myers, GD; August, KJ; Verneris, MR; Buechner, J; Laetsch, TW; Leung, M; Eldjerou, LK; June, CH; Maude, SL. Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia. Journal for ImmunoTherapy of Cancer. 2021; 9:e002287.

Ibrahimova, A; Davies, SM; Lane, A; Jordan, MB; Lake, K; Litts, B; Chaturvedi, V; Owsley, E; Myers, KC; Nelson, AS; Mehta, PA; Marsh, RA; Khandelwal, P. α4β7 Integrin expression and blockade in pediatric and young adult gastrointestinal graft-versus-host disease. Pediatric Blood and Cancer. 2021; 68:e28968.

Sabulski, A; Szabo, S; Myers, KC; Davies, SM; Jodele, S. Testicular thrombotic microangiopathy: An unrecognized complication. Pediatric Blood and Cancer. 2021; 68:e29128.

Dandoy, CE; Davies, SM; Ahn, KW; He, Y; Kolb, AE; Levine, J; Bo-Subait, S; Abdel-Azim, H; Bhatt, N; Chewing, J; Sharma, A; Shaw, P; Winestone, L; Eapen, M. Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children. Haematologica: the hematology journal. 2021; 106:1839-1845.

Wallace, G; Khandelwal, P; Myers, KC; Perentesis, EM R; Lane, A; Teusink-Cross, A; Smiley, K; Davies, SM; Jodele, S. Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease. Bone Marrow Transplantation. 2021; 56:1441-1444.

Jung, M; Mehta, PA; Jiang, CS; Rosti, RO; Usleaman, G; da Rosa, JM C; Lach, FP; Goodridge, E; Auerbach, AD; Davies, SM; Smogorzewska, A; Boulad, F. Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia. British Journal of Haematology. 2021; 193:971-975.

Ryan, TD; Moore, RA; Lang, SM; Khoury, P; Dandoy, CE; Davies, SM; Taylor, MD. Rapid cardiac MRI protocol for cardiac assessment in paediatric and young adult patients undergoing haematopoietic stem cell transplant: a feasibility study. Cardiology in the Young. 2021; 31:973-978.

Kumar, S; Nattamai, KJ; Hassan, A; Amoah, A; Karns, R; Zhang, C; Liang, Y; Shimamura, A; Florian, MC; Bissels, U; Davies, SM; Mulaw, M; Geiger, H; Myers, KC. Repolarization of HSC attenuates HSCs failure in Shwachman-Diamond syndrome. Leukemia. 2021; 35:1751-1762.

Wang, YZ M; Howell, JC; Grimley, MS; Lane, A; Davies, SM; Myers, KC. Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC). Pediatric Transplantation. 2021; 25:e13983.

Luebbering, N; Abdullah, S; Lounder, D; Lane, A; Dole, N; Rubinstein, J; Hewison, M; Gloude, N; Jodele, S; Perentesis, KM R; Lake, K; Litts, B; Duell, A; Dandoy, CE; Davies, SM. Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomes. Haematologica: the hematology journal. 2021; 106:1321-1329.

Stefanski, KJ; Anixt, JS; Goodman, P; Bowers, K; Leisenring, W; Scott Baker, K; Burns, K; Howell, R; Davies, S; Robison, LL; Armstrong, GT; Krull, KR; Recklitis, C. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report. Journal of the National Cancer Institute. 2021; 113:481-495.

Khandelwal, P; Yeh, RF; Yu, L; Lane, A; Dandoy, CE; El-Bietar, J; Davies, SM; Grimley, MS. Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa. Transplantation. 2021; 105:891-896.

Sauter, SL; Zhang, X; Romick-Rosendale, L; Wells, SI; Myers, KC; Brusadelli, MG; Poff, CB; Brown, DR; Panicker, G; Unger, ER; Mehta, PA; Bleesing, J; Davies, SM; Kovacic, MB. Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia. Cancers. 2021; 13:1368.

Ruiz-Torres, S; Brusadelli, MG; Witte, DP; Wikenheiser-Brokamp, KA; Sauter, S; Nelson, AS; Sertorio, M; Chlon, TM; Lane, A; Mehta, PA; Komurov, K; Kovacic, MB; Davies, SM; Wells, SI. Inherited DNA Repair Defects Disrupt the Structure and Function of Human Skin. Cell Stem Cell. 2021; 28:424-435.e6.

Tamburro, RF; Cooke, KR; Davies, SM; Goldfarb, S; Hagood, JS; Srinivasan, A; Steiner, ME; Stokes, D; DiFronzo, N; El-Kassar, N; Shelburne, N; Natarajan, A. Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary. Annals of the American Thoracic Society. 2021; 18:381-394.

Koo, J; Teusink-Cross, A; Davies, SM; Jodele, S; Dandoy, CE. 276 Single Center Results to Improve Peripheral Blood Stem Cell Mobilization Success in Pediatric and Young Adult Patients. Transplantation and Cellular Therapy. 2021; 27:s242.

Lipps, D; Zhu, X; Lutzko, C; Leemhuis, T; Cancelas, JA; Jodele, S; Keller, MD; Bollard, CM; Hanley, PJ; Rubinstein, JD; Davies, SM; Grimley, MS; Teusink-Cross, A; Nelson, AS. 433 T Cell Co-Stimulatory Blockade By CTLA4-Ig Does Not Appear to Impact the Clinical Efficacy of Viral Specific T Cell Therapy in Pediatric Patients after HSCT. Transplantation and Cellular Therapy. 2021; 27:s357-s358.

Wang, YM; Lipps, D; Wilson, B; Leemhuis, T; Cancelas, JA; Lane, A; Badia, P; Davies, SM; Dandoy, CE. 180 Beware Cells That Come in the Night: Time of Stem Cell Infusion As Risk Factor for Primary Graft Failure. Transplantation and Cellular Therapy. 2021; 27:s166-s167.

Rubinstein, JD; Lutzko, C; Leemhuis, T; Zhu, X; Ray, L; Thomas, S; Dourson, C; Wilhelm, J; Lane, A; Cancelas, JA; Wang, YM; Davies, SM; Nelson, AS; Grimley, MS. 91 Scheduled Donor-Derived Viral Specific T-Cells for Prophylaxis Against Double Stranded DNA Viral Infection after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2021; 27:s87-s88.

Sabulski, A; Davies, SM; Paulsen, G; Marsh, R; Chandra, S. BCG-osis and Hematopoietic Cell Transplant for Primary Immunodeficiencies. Journal of Clinical Immunology. 2021; 41:491-494.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Davies, SM; Laskin, BL; Blackard, JT. BK Polyomavirus Genotypes in Two Patients after Hematopoietic Cell Transplant. Editor, Roux S. Microbiology Resource Announcements. 2021; 10:e01122-e01120.

Dandoy, CE; Rotz, S; Alonso, PB; Klunk, A; Desmond, C; Huber, J; Ingraham, H; Higham, C; Dvorak, CC; Duncan, C; Chima, R; Lane, A; Davies, SM; Jodele, S. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Blood Advances. 2021; 5:1-11.

Bartlett, AL; Romick-Rosendale, L; Nelson, A; Abdullah, S; Luebbering, N; Bartlett, J; Brusadelli, M; Palumbo, JS; Lake, K; Litts, B; Lane, A; Myers, KC; Wells, SI; Davies, SM. Tryptophan metabolism is dysregulated in individuals with Fanconi anemia. Blood Advances. 2021; 5:250-261.

Chandra, S; Chandrakasan, S; Dávila Saldaña, BJ; Bleesing, JJ; Jordan, MB; Kumar, AR; Grimley, MS; Krupski, C; Davies, SM; Khandelwal, P; Marsh, RA. Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation. Journal of Clinical Immunology. 2021; 41:89-98.